Many resources are needed to download a project. Please understand that we have to compensate our server costs. Thank you in advance. Project price only 1 $
You can buy this project and download/modify it how often you want.
/**
* Autogenerated by Avro
*
* DO NOT EDIT DIRECTLY
*/
package org.gel.models.report.avro;
@SuppressWarnings("all")
/** N/A: Trials without phases (for example, studies of devices or behavioural interventions).
Early Phase 1 (Formerly listed as "Phase 0"): Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies). See FDA guidance on exploratory IND studies for more information.
Phase 1: Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
Phase 1/Phase 2: Trials that are a combination of phases 1 and 2.
Phase 2: Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
Phase 2/Phase 3: Trials that are a combination of phases 2 and 3.
Phase 3: Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
Phase 4: Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use. */
@org.apache.avro.specific.AvroGenerated
public enum StudyPhase {
na, early_phase1, phase1, phase1_phase2, phase2, phase2_phase3, phase3, phase4 ;
public static final org.apache.avro.Schema SCHEMA$ = new org.apache.avro.Schema.Parser().parse("{\"type\":\"enum\",\"name\":\"StudyPhase\",\"namespace\":\"org.gel.models.report.avro\",\"doc\":\"N/A: Trials without phases (for example, studies of devices or behavioural interventions).\\n Early Phase 1 (Formerly listed as \\\"Phase 0\\\"): Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies). See FDA guidance on exploratory IND studies for more information.\\n Phase 1: Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.\\n Phase 1/Phase 2: Trials that are a combination of phases 1 and 2.\\n Phase 2: Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.\\n Phase 2/Phase 3: Trials that are a combination of phases 2 and 3.\\n Phase 3: Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.\\n Phase 4: Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.\",\"symbols\":[\"na\",\"early_phase1\",\"phase1\",\"phase1_phase2\",\"phase2\",\"phase2_phase3\",\"phase3\",\"phase4\"]}");
public static org.apache.avro.Schema getClassSchema() { return SCHEMA$; }
}
